Obstetrics & Thrombophilias: What women want? - References
Review Article
Article Index
Obstetrics & Thrombophilias: What women want?
Thrombophilias & Pregnancy
Who should be tested for thrombophilias (APAs)?
All Pages


  1. Malpas P. A study of abortion sequence. J Obstet Gynaecol Br Emp 1938; 45:932.
  2. Eastman NJ. Habitual abortion, In: Meigs JV, Sturgis S, eds. Progress in Gynecology, Vol. 1, Grune & Stratton, New York, 1946
  3. Warburton D, Fraser FS. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964; 16:1.
  4. Poland BJ, Miller JR, Jones DC, Trimble BK. Reproductive counselling in patients who have had a spontaneous abortion. Am J Obstet Gynecol 1977; 127:685.
  5. Roman E. Fetal loss rates and their relation to pregnancy order. J Epidemiol Community Health 1984; 38:29.
  6. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage.  Hum Reprod 1997; 12:387.
  7. Lee RM, Silver RM. Recurrent pregnancy loss: summary and clinical implications. Seminars Reprod Med 2000; 18:433.
  8. Magon N. Thrombophilias and pregnancy. Int J Clin Cases Investig 2011. Available from: http://www.ijcci.info
  9. Fausett MB, Branch DW. Autoimmunity and pregnancy loss. Seminars Reprod Endocrinol 2000; 18:379.
  10. Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.  Obstet Gynecol 1997; 89:549.
  11. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369.
  12. Chamley LW, Pattison NS, McKay EJ. The effect of human anticardiolipin antibodies on murine pregnancy.  J Reprod Immunol 1994; 27:123.
  13. Branch DW. Immunologic disease and fetal death. Clin Obstet Gynecol 1987; 30:295.
  14. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87:489.
  15. Tulppala M, Viinikka L, Ylikorkala O. Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet 1991; 337:879.
  16. Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, Harpel PC. Pregnancy loss in the antiphospholipid-antibody syndrome — a possible thrombogenic mechanism. New Engl J Med 1997;  337:154.
  17. Di Simone N, Di Nicuolo F, D’lppolito S, Castellani R, Tersigni C, Caruso A, Meroni P, Marana R. Antiphospholipid antibodies affect human endometrial angiogenesis. Biol Reprod:Epub, April 14, 2010.
  18. Regan L, Rai R. Thrombophilia and pregnancy loss. J Reprod Immunol 2001; 55:163.
  19. Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4:397.
  20. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174:1584.
  21. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314:253.
  22. Tulppala M, Marttunen M, Söderström-Anttila V, Foudila T, Ailus K, Palosuo T, Ylikorkala O. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997; 12:1567.
  23. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999; 106:102.
  24. Empson M, Lassere M, Craig J, Scott J, Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant, Cochrane Database Syst Rev 18:CD002859, 2005.
  25. Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010; 115:1256.
  26. Laurent P, Dussarat GV, Bonal J, Jego C, Talard P, Bouchiat C, Cellarier G, Low molecular weight heparins: a guide to their optimum use in pregnancy. Drugs 2002; 62:463.
  27. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, Farine D, Spitzer K, Fielding L, Soloninka CA, Yeung M. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. New Engl J Med 1997; 337:148.
  28. Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo- controlled study. Arch Gynecol Obstet 2008; 278:33.
  29. Magon N. Gestational diabetes mellitus: Get, set, go - From diabetes capital of the world to diabetes care capital of the world. Indian J Endocr Metab 2011;15:161-9. Available online at http://www.ijem.in/text.asp?2011/15/3/161/83398
  30. Antiphospholipid Syndrome. ACOG Practice Bulletin No. 118 .American College of Obstetricians and Gynecologists. Obstet Gynecol 2011; 117 (1): 192-9.
  31. Scifres CM, Macones GA. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction? Am J Obstet Gynecol 2008;199:344.e1–344.e7.
  32. Inherited Thrombophilias in Pregnancy. ACOG Practice Bulletin No. 113 .American College of Obstetricians and Gynecologists. Obstet Gynecol 2010; 116 (1): 212-22.
  33. Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004734. DOI: 10.1002/14651858.CD004734.



Copyright © 2016 ijcci.info. All Rights Reserved.